Skip to main content
13/11/2005 - 20:35

Solbec anti-cancer compound gets good news from FDA

13/11/2005 - 20:35

Bookmark

Save articles for future reference.

Solbec Pharmaceuticals Limited has announced its lead anti-cancer compound Coramsine has received orphan drug designation from the US Food and Drug Administration.

X

To read our articles you will need to either login or subscribe.